ChronoScale Holdings Corporation is projected to rise to $29.43 by 2027, a +41% move from its current price of $20.90. CHRN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $19.45 | $20.91 | $22.48 | +0.05% |
| Jul 14 | $18.89 | $20.92 | $23.17 | +0.10% |
| Jul 15 | $18.47 | $20.93 | $23.72 | +0.15% |
| Jul 16 | $18.12 | $20.94 | $24.19 | +0.19% |
| Jul 17 | $17.83 | $20.95 | $24.62 | +0.24% |
| Jul 18 | $17.56 | $20.96 | $25.02 | +0.29% |
| Jul 19 | $17.32 | $20.97 | $25.39 | +0.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $17.32 | $20.97 | $25.39 | +0.34% |
| Week 2 | $16.06 | $21.04 | $27.57 | +0.68% |
| Week 3 | $15.17 | $21.11 | $29.40 | +1.02% |
| Week 4 | $14.46 | $21.19 | $31.04 | +1.37% |
| Week 5 | $13.87 | $21.26 | $32.59 | +1.71% |
| Week 6 | $13.36 | $21.33 | $34.06 | +2.06% |
| Week 7 | $12.91 | $21.40 | $35.48 | +2.41% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ChronoScale Holdings Corporation designs and develops a compute platform to support artificial intelligence workloads. It focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. The company is categorized in Technology and is based in Dallas, Texas.
ChronoScale Holdings Corporation trades under the symbol CHRN and currently carries a price of $20.34 with a market capitalization of $2.95B. It is ranked 1766 by market cap. The forecast profile suggests an upside path over the coming years, with the average price expanding from the 2026 level of $20.34 to higher figures in later years and a trajectory of rising ROIs.
A major floor 61.6% below — a decisive break under it would weaken the trend.
The nearest floor, 21.1% below — buyers have tended to step in here.
The nearest ceiling, 23.5% above — a clean break opens room to run.
A major ceiling 45.5% above — clearing it would confirm fresh momentum.
Key CHRN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CHRN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.01 | Buy | $19.65 | Buy |
| MA 10 | $19.65 | Buy | $19.75 | Buy |
| MA 20 | $20.53 | Buy | $19.77 | Buy |
| MA 50 | $17.86 | Buy | $17.90 | Buy |
| MA 100 | $14.26 | Buy | $15.10 | Buy |
| MA 200 | $10.20 | Buy | $12.14 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.36 | Neutral |
| Stoch RSI (14) | 41.24 | Neutral |
| CCI (20) | 10.75 | Neutral |
| Williams %R (14) | -52.73 | Info |
| MACD (12,26,9) | -0.40 | Sell |
| ROC (12) | -19.05 | Sell |
| Bollinger %B (20,2) | 0.53 | Neutral |
| Stochastic %K (14) | 47.27 | Neutral |
| TRIX (15) | 0.61 | Buy |
| Awesome (5,34) | -0.44 | Sell |
| Ultimate (7,14,28) | 45.44 | Neutral |
| Momentum (10) | -1.61 | Sell |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 19.38 | Buy |
| ADX (14) | 17.95 | Neutral |
| ATR (14) | 1.29 | Info |
The near-term technical picture remains bullish in sentiment, with RSI14 at 50 and a price structure that supports upside potential ahead of key levels. The 50-day simple moving average sits at $17.67 while the 200-day simple moving average sits at $10.12, indicating evolving momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.84 | $20.90 | $32.94 | 0% | Neutral | |
| $21.35 | $29.43 | $43.86 | +41% | Bullish | |
| $31.87 | $46.68 | $74.12 | +123% | Bullish | |
| $35.28 | $54.43 | $90.75 | +160% | Bullish | |
| $37.41 | $60.51 | $105.01 | +190% | Bullish | |
| $39.06 | $66.03 | $118.62 | +216% | Bullish | |
| $32.25 | $56.87 | $105.34 | +172% | Bullish | |
| $40.21 | $73.85 | $140.59 | +253% | Bullish | |
| $54.49 | $104.09 | $203.19 | +398% | Bullish | |
| $56.80 | $112.79 | $225.28 | +440% | Bullish | |
| $67.20 | $149.34 | $327.83 | +615% | Bullish | |
| $180.41 | $400.91 | $922.09 | +18.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $7.84 | $20.90 | $26.09 | +0.00% |
| August 2026 | $17.15 | $20.77 | $26.20 | -0.62% |
| September 2026 | $17.78 | $21.85 | $28.14 | +5.17% |
| October 2026 | $19.79 | $24.61 | $32.25 | +12.66% |
| November 2026 | $20.04 | $25.18 | $33.48 | +2.32% |
| December 2026 | $19.27 | $24.45 | $32.94 | -2.91% |
Click any year to see its month-by-month CHRN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CHRN to range from $7.84 to $32.94 through 2026. The $20.90 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CHRN price prediction for 2027 points to an average of $29.43 (low $21.35, high $43.86) — a potential gain of +41% on today's $20.90. Buyers look set to stay in control over this stretch.
In 2028, CHRN is projected to trade between $31.87 and $74.12, averaging $46.68 — a potential gain of +123% from today's $20.90. That is up +59% on the projected 2027 average. Momentum favours further upside here.
ChronoScale Holdings Corporation's 2029 outlook centres on $54.43, within a $35.28 to $90.75 range. That is up +17% on the projected 2028 average. That marks a +160% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CHRN could reach as high as $105.01, with a base case around $60.51 and support toward $37.41 — roughly +190% from $20.90. Momentum favours further upside here.
Expect CHRN to range from $39.06 to $118.62 through 2031. The $66.03 average target implies a +216% move from current prices. That is up +9% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CHRN price prediction for 2032 points to an average of $56.87 (low $32.25, high $105.34) — a potential gain of +172% on today's $20.90. Momentum favours further upside here.
In 2033, CHRN is projected to trade between $40.21 and $140.59, averaging $73.85 — a potential gain of +253% from today's $20.90. That is up +30% on the projected 2032 average. Buyers look set to stay in control over this stretch.
ChronoScale Holdings Corporation's 2034 outlook centres on $104.09, within a $54.49 to $203.19 range. That is up +41% on the projected 2033 average. That marks a +398% change versus current levels. Momentum favours further upside here.
By 2035, CHRN could reach as high as $225.28, with a base case around $112.79 and support toward $56.80 — roughly +440% from $20.90. Buyers look set to stay in control over this stretch.
Expect CHRN to range from $67.20 to $327.83 through 2040. The $149.34 average target implies a +615% move from current prices. That is up +32% on the projected 2035 average. Momentum favours further upside here.
The CHRN price prediction for 2050 points to an average of $400.91 (low $180.41, high $922.09) — a potential gain of +18.2x on today's $20.90. Buyers look set to stay in control over this stretch.
Investing $1,000 in CHRN today (≈ 47.84689 CHRN) could be worth
$19,182.26
+$18,182.26 (+1818%) by 2050 · US Dollar
Based on the average projected CHRN price of $400.91 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CHRNwould be worth at today's price.
$1,000 invested in CHRN on Jul 10, 2025 (≈ 289.855068 CHRN) would be worth
$6,057.97
+$5,057.97 (+505.8%) today · 6.06× · US Dollar
Based on a CHRN entry price of $3.45 vs. today's $20.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $16.49 | $1,267.43 | +26.7% |
| 1 month ago | $17.24 | $1,212.3 | +21.2% |
| 3 months ago | $9.02 | $2,317.07 | +131.7% |
| 6 months ago | $8.78 | $2,380.41 | +138.0% |
| 1 year ago | $3.45 | $6,057.97 | +505.8% |
| All time (5.0y) ago | $74.55 | $280.35 | -72.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CHRN forecast.
Our base-case forecast reaches $42.00 around 2028.
Implied market cap at $42.00: $6.1B
The multi-year forecast shows sustained upside, with 2027 avg $28.77 and 2027 min $20.86 and max $42.89 (ROI 41.4%). By 2030, the avg rises to $59.53 with a max of $103.33 and a min of $36.79 (ROI 192.7%), and the sentiment remains bullish. The trajectory continues through 2040 with an avg of $147.17 and a max of $323.10 (ROI 623.6%), and into 2050 with an avg of $398.55 and a max of $916.67 (ROI 1859.4%).
These figures reflect a bullish long-run outlook, though they come with significant volatility and uncertainty.
Tap a question to reveal the answer.
The forecast shows a min of $36.79, an average of $59.53, and a max of $103.33 in 2030, with a projected ROI of 192.7% and bullish sentiment.
Forecasts indicate bullish sentiment in most years after 2026, with the average price rising to $59.53 by 2030 and an ROI of 192.7% in that year; note that 2026 is neutral and outcomes are not guaranteed.
Yes. The forecasted maximum price for 2030 is $103.33.
Current price is $20.34 and market capitalization is $2.95B.
The 2040 forecast shows an average price of $147.17, a min of $66.23, a max of $323.10, with ROI of 623.6 and bullish sentiment.
ChronoScale Holdings Corporation Community Discussion
0Share your ChronoScale Holdings Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.